Cazal 0,5 mg/g + 1,0 mg/g krema
| Name | Cazal 0,5 mg/g + 1,0 mg/g krema |
|---|---|
| Marketing Authorisation Number | HR-H-827387669 |
| Active Substance | betametazondipropionat gentamicinsulfat |
| Composition | jedan gram kreme sadrži 0,5 mg betametazona (u obliku 0,64 mg betametazondipropionata) i 1 mg gentamicina (u obliku 1,67 mg gentamicinsulfata) |
| Pharmaceutical Form | krema |
| Manufacturer | mibe GmbH Arzneimittel, Brehna, Njemačka |
| Marketing Authorisation Holder | Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska |
| Marketing Authorisation Date | 20.07.2021 |
| MA Period of Validity | 20.07.2026 |
| Classification Number | UP/I-530-09/18-01/46 |
| Registration Number | 381-12-01/38-21-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | D07CC01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
